Influence of human papillomavirus type 16 gene expression on in vitro differentiation of the human teratocarcinoma cell line 2102Ep

1996 ◽  
Vol 16 (2) ◽  
pp. 109-114 ◽  
Author(s):  
Hubert Stöppler ◽  
Tatjana Kirchhoff ◽  
Jürgen Kartenbeck ◽  
Lutz Gissmann ◽  
Angel Alonso
Keyword(s):  
Gene Expression ◽  
Human Papillomavirus ◽  
Cell Line ◽  
In Vitro Differentiation ◽  
Teratocarcinoma Cell ◽  
Human Papillomavirus Type 16 ◽  
Teratocarcinoma Cell Line

Alterations of cellular characteristics of a human ovarian teratocarcinoma cell line after in vitro treatment with retinoids

1990 ◽  
Vol 43 (2) ◽  
pp. 123-130 ◽  
Author(s):  
Douglas D. Taylor ◽  
Cicek Gercel Taylor ◽  
Paul H. Black ◽  
Cheng-gan Jiang ◽  
Iih-Nan Chou
Keyword(s):  
Cell Line ◽  
Teratocarcinoma Cell ◽  
Teratocarcinoma Cell Line ◽  
In Vitro Treatment

In vitro differentiation of the murine macrophage cell line BDM-1 into osteoclast-like cells.

Endocrinology ◽  
1995 ◽  
Vol 136 (10) ◽  
pp. 4285-4292 ◽  
Author(s):  
J H Shin ◽  
A Kukita ◽  
K Ohki ◽  
T Katsuki ◽  
O Kohashi
Keyword(s):  
Cell Line ◽  
Murine Macrophage ◽  
In Vitro Differentiation ◽  
Macrophage Cell Line ◽  
Macrophage Cell ◽  
Murine Macrophage Cell Line

Cloning and sequencing of the murine farnesyltransferase α-encoding cDNA from a cell line which expresses the human papillomavirus type-16 E6 gene

Gene ◽  
1995 ◽  
Vol 164 (2) ◽  
pp. 373-374 ◽  
Author(s):  
Hiroshi Shirasawa ◽  
Tomoaki Kinoshita ◽  
Yuji Shino ◽  
Kohji Mori ◽  
Kumiko Shimizu ◽  
...  
Keyword(s):  
Human Papillomavirus ◽  
Cell Line ◽  
Cloning And Sequencing ◽  
Human Papillomavirus Type 16 ◽  
E6 Gene ◽  
A Cell

scholarly journals Does Bromelain-Cisplatin Combination Afford In-Vitro Synergistic Anticancer Effects on Human Prostatic Carcinoma Cell Line, PC3?

2020 ◽  
Vol 9 ◽  
pp. 1749
Author(s):  
Fatemeh Amini Chermahini ◽  
Elham Raeisi ◽  
Mathias Hossain Aazami ◽  
Abbas Mirzaei ◽  
Esfandiar Heidarian ◽  
...  
Keyword(s):  
Gene Expression ◽  
Cell Viability ◽  
Cell Line ◽  
Colony Formation ◽  
Prostatic Carcinoma ◽  
Carcinoma Cell ◽  
Quantitative Polymerase Chain Reaction ◽  
Chemotherapeutic Agents ◽  
Carcinoma Cell Line

Background: Bromelain enhances anticancer impacts to chemotherapeutic agents. The question as to whether bromelain does promote in-vitro cytotoxic and proapoptotic effects of cisplatin on human prostatic carcinoma PC3 cell line was investigated. Materials and Methods: PC3 (human prostatic carcinoma) cells were treated either single or in combination with bromelain and/or cisplatin. MTT, clonogenic assay, flow cytometry and real-time quantitative polymerase chain reaction were used to investigate cell viability, colony formation, proapoptotic potential and p53 gene expression, respectively. Results: Cisplatin (IC10) combined with bromelain (IC40) significantly affected PC3 cell viability, inhibited colony formation, as well increased p53 proapoptotic gene expression compared to cisplatin single treatment. Nevertheless, bromelain-cisplatin chemoherbal combination did not display any additive proapoptotic effect compared to single treatments. Conclusion: Bromelain-cisplatin chemoherbal combination demonstrated synergistic in-vitro anticancer effect on human prostatic carcinoma cell line, PC3, that drastically reduced required cisplatin dose. [GMJ.2020;9:e1749]

Sign in / Sign up

Export Citation Format

Share Document